formic acid has been researched along with Malaria in 3 studies
formic acid: RN given refers to parent cpd
formic acid : The simplest carboxylic acid, containing a single carbon. Occurs naturally in various sources including the venom of bee and ant stings, and is a useful organic synthetic reagent. Principally used as a preservative and antibacterial agent in livestock feed. Induces severe metabolic acidosis and ocular injury in human subjects.
Malaria: A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia.
Excerpt | Relevance | Reference |
---|---|---|
"Pyronaridine is a known antimalarial drug that has received renewed interest as a partner drug in artemisinin-based combination therapy." | 5.46 | Quantification of the antimalarial drug pyronaridine in whole blood using LC-MS/MS - Increased sensitivity resulting from reduced non-specific binding. ( Blessborn, D; Day, NPJ; Kaewkhao, K; Song, L; Tarning, J; White, NJ, 2017) |
"To study the pharmacokinetic profile of artemether in children and in the context of antiviral drugs for HIV infected patients co-infected with malaria, an LC-MS/MS method was developed and validated to simultaneously determine artemether and its metabolite dihydroartemisinin in human plasma." | 3.75 | Development and validation of a high-performance liquid chromatography/tandem mass spectrometry method for the determination of artemether and its active metabolite dihydroartemisinin in human plasma. ( Aweeka, FT; Huang, L; Jayewardene, AL; Li, X; Lizak, PS; Marzan, F, 2009) |
"Pyronaridine is a known antimalarial drug that has received renewed interest as a partner drug in artemisinin-based combination therapy." | 1.46 | Quantification of the antimalarial drug pyronaridine in whole blood using LC-MS/MS - Increased sensitivity resulting from reduced non-specific binding. ( Blessborn, D; Day, NPJ; Kaewkhao, K; Song, L; Tarning, J; White, NJ, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blessborn, D | 1 |
Kaewkhao, K | 1 |
Song, L | 1 |
White, NJ | 1 |
Day, NPJ | 1 |
Tarning, J | 1 |
Huang, L | 1 |
Jayewardene, AL | 1 |
Li, X | 1 |
Marzan, F | 1 |
Lizak, PS | 1 |
Aweeka, FT | 1 |
Grieger, M | 1 |
Siems, W | 1 |
Müller, M | 1 |
Leppin, K | 1 |
3 other studies available for formic acid and Malaria
Article | Year |
---|---|
Quantification of the antimalarial drug pyronaridine in whole blood using LC-MS/MS - Increased sensitivity resulting from reduced non-specific binding.
Topics: Antimalarials; Artemisinins; Chromatography, Liquid; Cross-Over Studies; Drug Interactions; Formates | 2017 |
Development and validation of a high-performance liquid chromatography/tandem mass spectrometry method for the determination of artemether and its active metabolite dihydroartemisinin in human plasma.
Topics: Antimalarials; Artemether; Artemisinins; Calibration; Chromatography, High Pressure Liquid; Formates | 2009 |
[Effect of formate on mouse erythrocytes in vivo and in vitro].
Topics: Animals; Erythrocytes; Formates; Glutathione; Heinz Bodies; In Vitro Techniques; Malaria; Male; Mice | 1983 |